North America Advanced Computed Tomography Scanners Market Size, Share, and Growth Forecast 2026 - 2033

The North America advanced computed tomography scanners market is expected to be valued at US$ 3.2 billion in 2026 and is projected to reach US$ 4.3 billion, growing at a CAGR of 4.2% between 2026 and 2033.

The North America advanced computed tomography scanners market is expanding as healthcare providers prioritize faster, high-resolution, and lower-dose diagnostic imaging. Adoption is supported by rising cancer, cardiovascular, and neurological disease burdens, increasing imaging volumes, and continued investments in advanced hospital infrastructure. High-slice and photon-counting CT systems are gaining momentum because they provide enhanced spatial resolution, spectral information, and dose efficiency, particularly for cardiac and oncology applications.

AI-enabled reconstruction and workflow optimization are further improving image quality and operational efficiency. Portable CT systems are also gaining traction in intensive care, emergency, and point-of-care settings, supporting broader access to advanced imaging.

Drivers - Rising Burden of Chronic and Cardiovascular Diseases

The rising burden of chronic diseases across the U.S. and Canada continues to drive demand for advanced computed tomography imaging. The Centers for Disease Control and Prevention estimates that heart disease and cancer collectively account for a substantial share of annual deaths nationwide, encouraging hospitals to expand diagnostic imaging capacity for earlier detection and treatment planning.

The American College of Radiology has emphasized the growing clinical reliance on CT angiography and low-dose lung cancer screening protocols, both of which require advanced scanner capabilities beyond conventional systems. As healthcare providers prioritize precision diagnostics to manage rising chronic disease caseloads, demand for cone-beam, spectral imaging, and low-dose CT scanners continues to strengthen across hospital radiology departments, ambulatory surgical centers, and specialized diagnostic imaging facilities throughout North America.

Technological Advancements in Spectral Imaging and AI-Assisted Reconstruction

Continuous innovation in spectral imaging and artificial intelligence-based reconstruction algorithms is significantly enhancing diagnostic accuracy while reducing radiation exposure, a critical consideration emphasized by the U.S. Food and Drug Administration in its ongoing dose-reduction initiatives. Manufacturers including GE HealthCare Technologies Inc. and Siemens Healthineers AG have introduced dual-energy and photon-counting spectral CT platforms capable of differentiating tissue composition with greater precision than conventional systems.

The National Electrical Manufacturers Association has also published updated dose-optimization standards that support hospital adoption of next-generation scanners. As radiology departments increasingly prioritize both diagnostic clarity and patient safety, spectral imaging and AI-enabled reconstruction technologies are becoming important purchasing criteria, prompting continuous equipment upgrades across hospitals, diagnostic centers, and ambulatory surgical facilities throughout the region.

Restraints - High Capital and Maintenance Costs Limiting Adoption Among Smaller Facilities

Advanced computed tomography systems, particularly spectral imaging and cone-beam platforms, require substantial capital investment along with recurring maintenance, calibration, and software licensing costs. Smaller diagnostic centers and ambulatory surgical facilities, which often operate with constrained capital budgets, frequently cite affordability as a leading barrier to upgrading legacy scanner fleets, according to hospital association procurement surveys.

The American Hospital Association has noted that rural and independent health care facilities face heightened financial pressure when evaluating high-cost imaging equipment purchases. This cost sensitivity continues to slow broader adoption of premium advanced CT systems outside large hospital networks, creating a persistent equipment gap between well-capitalized academic medical centers and smaller community-based diagnostic providers across North America.

Radiation Exposure Concerns and Stringent Regulatory Compliance Requirements

Despite continuous dose-reduction advancements, cumulative radiation exposure from repeated computed tomography scans remains a persistent clinical and regulatory concern. The U.S. Food and Drug Administration continues to enforce compliance requirements under its radiation-emitting product performance standards, requiring manufacturers to undergo rigorous premarket testing and post-market surveillance. These regulatory requirements can extend the time required to introduce new advanced CT platforms, particularly novel spectral and photon-counting systems.

Additionally, radiologist and physician associations continue to advocate for conservative scan protocols to minimize unnecessary exposure, which can limit scan frequency in certain clinical settings. Together, these regulatory and clinical considerations moderate the pace of advanced CT scanner deployment across certain hospital networks despite strong underlying diagnostic demand.

Opportunities - Expansion of Spectral Imaging Technology Across Diagnostic and Oncology Applications

The rapid adoption of spectral imaging-based CT scanners presents a substantial opportunity for manufacturers and health care providers seeking to differentiate their diagnostic offerings. Spectral and dual-energy CT technology enables enhanced tissue characterization, improved contrast resolution, and better detection of subtle oncological and vascular abnormalities compared with conventional imaging. Companies such as Canon Medical Systems Corporation and Koninklijke Philips N.V. continue to expand their spectral imaging portfolios in response to growing clinical demand from oncology and cardiology departments.

The American College of Radiology has highlighted spectral CT's expanding role in personalized treatment planning, particularly for complex oncological cases requiring precise tumor characterization. As hospitals and specialized diagnostic centers increasingly prioritize advanced tissue differentiation capabilities, manufacturers that accelerate spectral imaging innovation are well positioned to capture incremental demand across both academic and community health care settings throughout North America.

Growing Demand for Portable and Point-of-Care CT Imaging Solutions

Rising interest in portable computed tomography systems is creating opportunities for manufacturers targeting emergency care, intensive care units, and point-of-care diagnostic environments. Portable CT platforms developed by companies such as Xoran Technologies, LLC and Samsung Electronics Co., Ltd. through its NeuroLogica Corp. subsidiary allow clinicians to perform rapid bedside imaging without transporting critically ill patients to fixed radiology suites.

The American Hospital Association has noted growing hospital interest in decentralized imaging solutions that reduce patient transport risks and accelerate diagnostic turnaround in trauma and neurocritical care settings. As emergency departments and intensive care units continue to modernize diagnostic workflows, demand for compact, mobile CT systems is expected to expand, offering manufacturers an avenue to capture rising institutional interest in flexible, decentralized imaging infrastructure across hospitals throughout the region.

Product Type Insights

Cone-beam CT scanners represent the leading product type segment, accounting for an estimated 41% share of the North American advanced computed tomography scanners market in 2026. This leadership stems from cone-beam technology's widespread adoption across dental, maxillofacial, orthopedic, and interventional radiology applications, where its compact footprint and lower radiation dose profile make it particularly suitable for point-of-care diagnostic settings. The American College of Radiology has recognized the expanding role of cone-beam CT in image-guided interventional procedures, further supporting clinical adoption of the technology.

Leading manufacturers, including Planmeca Group and Koning Corporation, continue to enhance cone-beam platforms with improved image resolution and workflow integration. Given their established clinical utility across multiple specialty applications and continued technological refinement, cone-beam CT scanners are expected to retain their leadership position throughout the forecast period.

Spectral imaging-based CT scanners represent the fastest-growing product type, driven by increasing demand for enhanced tissue characterization, improved contrast resolution, and more precise visualization of complex anatomical structures. Growing adoption in oncology, cardiology, and vascular imaging, along with advancements in dual-energy and photon-counting technologies, is further supporting segment growth as health care providers seek more detailed diagnostic information from a single imaging examination.

End-User Insights

Hospitals represent the dominant end-user segment in the North American advanced computed tomography scanners market, accounting for an estimated 68% share in 2026. Hospitals continue to serve as the primary point of access for advanced diagnostic imaging due to their comprehensive radiology infrastructure, higher patient volumes, and capacity to support capital-intensive equipment investments. The American Hospital Association reports that hospital-based imaging departments perform a substantial share of advanced CT procedures nationwide, reflecting their central role within the broader diagnostic imaging ecosystem.

Large hospital systems and academic medical centers continue to prioritize upgrades to spectral imaging and low-dose CT platforms to support complex oncology, cardiology, and trauma care protocols. As hospitals increasingly consolidate advanced imaging services to support multispecialty diagnostic workflows, this segment is expected to maintain its leadership position throughout the forecast period, supported by sustained capital investment in radiology infrastructure.

U.S. Advanced Computed Tomography Scanners Market Trends and Insights

The U.S. dominates the North American advanced computed tomography scanners market, accounting for an estimated 85% share in 2026, driven by extensive hospital infrastructure, high per-capita diagnostic imaging utilization, and strong reimbursement support through Medicare and Medicaid diagnostic imaging coverage policies. The Centers for Medicare & Medicaid Services continues to support reimbursement for advanced imaging modalities, encouraging hospitals to invest in next-generation CT platforms.

The U.S. Food and Drug Administration's continued clearance of spectral and low-dose CT systems further supports market confidence. The strong presence of leading manufacturers, including GE HealthCare Technologies Inc. and Carestream Health, Inc., alongside robust demand from academic medical centers for advanced oncology and cardiology imaging, continues to reinforce the country's leadership position within the broader North American market throughout the forecast period.

Canada Advanced Computed Tomography Scanners Market Trends and Insights

Canada represents a steadily expanding market, supported by ongoing provincial health care infrastructure investments and initiatives aimed at reducing diagnostic imaging wait times. Statistics Canada has reported consistent growth in diagnostic imaging procedure volumes across provincial health systems, reflecting sustained demand for advanced CT capacity. Health Canada's continued regulatory clearance of next-generation spectral and low-dose CT systems is further supporting hospital procurement decisions across major metropolitan centers such as Toronto, Vancouver, and Montreal.

Provincial health authorities continue to prioritize imaging capacity expansion to address diagnostic backlogs, particularly for oncology and cardiovascular screening programs. As Canadian hospitals increasingly adopt dose-optimized imaging protocols in line with national radiation safety guidelines, demand for advanced CT scanners is expected to grow steadily across public hospital networks and private diagnostic imaging clinics throughout the forecast period.

The North America advanced computed tomography scanners market remains moderately consolidated, with a handful of established global medical imaging manufacturers commanding significant market presence alongside specialized niche technology providers. Leading players such as GE HealthCare Technologies Inc., Siemens Healthineers AG, and Koninklijke Philips N.V. leverage extensive research and development capabilities, broad product portfolios, and established hospital relationships to maintain competitive advantage.

Meanwhile, specialized manufacturers including Xoran Technologies, LLC and Koning Corporation differentiate through niche, purpose-built platforms targeting portable and cone beam imaging applications. Continuous investment in spectral imaging innovation, artificial intelligence-assisted reconstruction, and radiation dose optimization remains central to competitive strategy across the industry. Many manufacturers are also pursuing strategic partnerships with academic medical centers and expanding service and maintenance offerings to strengthen long-term customer relationships and differentiate beyond core hardware performance across the region.

Key Industry Developments

• In December 2025, GE HealthCare entered into a multi-year agreement with Indonesia’s Ministry of Health to supply more than 300 advanced CT scanners to public hospitals across all 38 provinces under the Strengthening Indonesia’s Health Referral Network (SIHREN) program.
• In November 2025, Philips launched Verida, described as the world’s first detector-based spectral CT system fully powered by AI. The system integrates AI across image acquisition and reconstruction to improve image quality, reduce noise, accelerate workflows, and support dose-efficient imaging.